呼吁改进与癌症相关的尾症的编码
Marcus D Goncalves1, Richard F Dunne2, Amy C Moore3
1NYU Langone Health, New York, NY.
JCO oncology practice
|January 13, 2025
概括
确切诊断和编码癌症缓冲症至关重要,但由于缺乏标准化的护理和重叠的症状,这是一个挑战. 改善这些方面将提高患者的护理和提前治疗.
科学领域:
- 在瘤学瘤学.
- 代谢医学是一种代谢医学.
背景情况:
- 癌症患者的全身性疲劳综合症 (Cachexia) 严重影响生活质量,医疗费用和治疗结果.
- 尽管其患病率和临床意义很高,但黄昏症经常被诊断不足,缺乏正式编码,阻碍了有效的管理和研究.
- 诊断的障碍包括缺乏标准化疗法,对准确编码的激励不足,以及与其他疾病重叠的临床特征.
研究的目的:
- 识别和解决癌症缓解症的准确诊断和编码的障碍.
- 区分卡赫西亚和相关疾病,如无意减肥,肉症,虚弱和蛋白质热量营养不良.
- 提出一个框架,改进缓解症的诊断和编码,以促进更好的患者护理和治疗开发.
主要方法:
- 审查现有的文学卡赫克西亚诊断和编码挑战.
- 对临床特征的比较分析,区分卡赫克西亚和类似疾病.
- 开发一种提议的方法来提高诊断准确性和编码实践.
主要成果:
- 确定了关键的诊断和编码障碍,包括缺乏标准化治疗和编码激励措施,以及症状重叠.
- 勾勒出卡赫西亚与萨尔科佩尼亚和营养不良等疾病之间的明显的临床特征和相互关系.
- 提出了一种结构化的方法来改善缓解症的诊断和编码.
结论:
- 增强的诊断准确性和缓冲症的编码对于改善患者识别,分层和管理至关重要.
- 这种改进的框架将支持基于机制的治疗方法的开发,并促进美国食品和药物管理局等监管机构批准先进的治疗方法.
- 解决诊断和编码挑战对于推进缓解症研究和临床护理领域至关重要.
相关概念视频
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
01:21Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K